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1. Introduction
Cardiovascular diseases are collectively the leading causes 
of death in the United States, with diseases of the heart ac-
counting for over 25% of all deaths in the United States [1]. El-
evated circulating low-density lipoprotein (LDL) cholesterol 
has long been considered a risk factor for the development of 
atherosclerotic lesions, which may ultimately lead to impaired 
blood circulation, heart attacks and strokes. Several pharma-
ceutical and nutraceutical therapies are presently available to 
decrease LDL cholesterol, including the consumption of plant 
sterol and stanol esters (here, collectively referred to as phy-
tosterol esters) [2].
Presently, one mechanism by which phytosterols are 
thought to exert their cholesterol-lowering effects is by de-
creasing the incorporation of cholesterol into micelles [3], 
thereby decreasing absorption and increasing excretion of 
cholesterol [4]. In in vitro models, only free phytosterols are 
shown to be effective in displacing cholesterol [5], while the 
physiological effects are demonstrated in vivo by both free 
and esterified phytosterols. This leads to the hypothesis that 
phytosterol esters must be hydrolyzed to impart their cho-
lesterol-lowering effects, which is supported by the observa-
tion that supplementation of phytosterol esters increases the 
amounts of free phytosterols and cholesterol in feces [4]. Pan-
creatic cholesterol esterase (PCE; EC 3.1.1.13) has been sug-
gested as the enzyme responsible for the hydrolysis of phytos-
terol esters. To date, however, no research has been conducted 
to confirm whether PCE hydrolyzes these esters, much less 
whether PCE selectively hydrolyzes various sterol esters.
Efficient absorption of dietary cholesterol esters is depen-
dent on hydrolysis by PCE, followed by the subsequent sol-
ubilization of free cholesterol by gall bladder secretions to 
form mixed micelles in the intestinal lumen; free phytoster-
ols are also solubilized in this way [5]. Furthermore, the pu-
tative intestinal cholesterol transporter Niemann-Pick C1-
Like 1 (NPC1L1) transports free sterols but not sterol esters 
[6]. Thus, it appears that the hydrolysis of cholesterol esters 
is necessary for the cholesterol from these esters to be effi-
ciently micellarized and absorbed, while hydrolysis of phy-
tosterol esters may be necessary to impart their cholesterol-
lowering properties.
PCE is a broad lipid-ester hydrolase, hydrolyzing other 
lipid carboxyl esters in addition to cholesterol esters [7, 8]. The 
hydrolytic activity is not uniform across substrates, however, 
as the diacylglycerol lipase activity of PCE is greater than its 
triacylglycerol lipase activity [7], and the phospholipase A1 ac-
tivity of PCE is greater than its phospholipase A2 activity [8]. 
Because of the documented differences in substrate specifici-
ties, we hypothesized that PCE hydrolyzes phytosterol esters, 
and that the rate of hydrolysis depends on both the sterol and 
fatty acid moieties.
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Abstract
Consumption of plant sterols or stanols (collectively referred to as phytosterols) and their esters results in decreased low-
density lipoprotein cholesterol, which is associated with decreased atherosclerotic risk. The mechanisms by which phytos-
terols impart their effects, however, are incompletely characterized. The objective of the present study is to determine if 
pancreatic cholesterol esterase (PCE; EC 3.1.1.13), the enzyme primarily responsible for cholesterol ester hydrolysis in the 
digestive tract, is capable of hydrolyzing various phytosterol esters and to compare the rates of sterol ester hydrolysis in 
vitro. We found that PCE hydrolyzes palmitate, oleate and stearate esters of cholesterol, stigmasterol, stigmastanol and si-
tosterol. Furthermore, we found that the rate of hydrolysis was dependent on both the sterol and the fatty acid moieties 
in the following order of rates of hydrolysis: cholesterol > (sitosterol = stigmastanol) > stigmasterol; oleate > (palmitate = 
stearate). The addition of free phytosterols to the system did not change hydrolytic activity of PCE, while addition of pal-
mitate, oleate or stearate increased activity. Thus, PCE may play an important but discriminatory role in vivo in the libera-
tion of free phytosterols to compete with cholesterol for micellar solubilization and absorption.
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2. Methods and Materials
2.1. Reagents
Stigmasterol (95%) and stearoyl chloride (90%) were purchased from 
TCI America (Portland, OR, USA). Sitosterol (75%), cholesteryl stearate 
(96%), cholesteryl palmitate (97%) and palmitoyl chloride (98%) were pur-
chased from ACROS Organics (Geel, Belgium). Oleoyl chloride (85%), so-
dium cholate hydrate (99%), cholesteryl oleate (98%), oleic acid (99%), stea-
ric acid (99%), Sylon BTZ and palladium on carbon (Pd/C, 10%) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 5α-Cholestane was ob-
tained from Steraloids (Newport, RI, USA). Cholesterol (95%) was obtained 
from Mallinckrodt OR (Paris, KY, USA). W2 Raney Nickel (RaNi) was pre-
pared by reaction of NiAl2 alloy and NaOH as previously described [9]. Pal-
mitic acid (99+%), Triton X-100 and porcine pancreatic cholesterol ester-
ase (Cat. no. 0215067180) were obtained from MP Biomedicals (Irvine, CA, 
USA). PCE contained the trace enzyme contaminants of 0.0098% chymotryp-
sin, < 0.0004% glucose oxidase, 0.432% trypsin and < 0.0001% uricase, as de-
termined by the manufacturer, none of which should alter lipid metabolism.
2.2. Phytosterol ester preparation
Stigmasterol was used as supplied by the manufacturer in subsequent 
preparations.
Stigmastanol (a.k.a. sitostanol) was prepared from stigmasterol as pre-
viously described [10, 11]. Briefly, 1.06 g (1 mmol) of Pd/C was added to 
400 ml of a 45 mM stirred solution of stigmasterol in 2-propanol. The reac-
tion mixture was stirred under an atmosphere (balloon) of hydrogen gas at 
60°C overnight, after which the Pd/C was removed by filtration through a 
pad of Celite. The resulting solution was concentrated at reduced pressure 
to provide a quantitative yield of pure stigmastanol (mp 139–140°C; liter-
ature 140°C [12]). The lack of a residual alkene was verified by 1H NMR.
Sitosterol of relatively high purity (92%) was prepared through a three-
step procedure [10]. First, 4.4 g (10 mmol) of stigmasterol were hydroge-
nated using 3.4 g RaNi in 350 ml of ethyl acetate under an atmosphere 
(balloon) of hydrogen gas; the reduction step was monitored by gas chro-
mathography/mass spectrometry, using an AT-5 column (Alltech Associ-
ates, Deerfield, IL, USA; 0.32 mm×30 m). Once the hydrogenation had con-
sumed most of the stigmasterol (typically 10 h), the RaNi was removed by 
filtration through a pad of Celite and the solvent was removed at reduced 
pressure. The crude residue was analyzed by 1H NMR and determined to 
consist of a 7:80:13 mixture of stigmasterol, sitosterol and stigmastanol, 
based upon the relative integration of the signals at 0.720, 0.702 and 0.671 
ppm, respectively. Second, the mixture of sterols was dissolved in 100 ml 
of ether and treated dropwise with 20 ml of 0.6 M bromine in ether at room 
temperature. The reaction flask was then stoppered and stored at −20°C 
for 3 days. Crystals, which were residual stigmastanol (confirmed by TLC), 
were removed by filtration and the filtrate was concentrated in vacuum. 
The residue was purified by flash column chromatography with 10% ethyl 
acetate in hexane to furnish sitosterol 5,6-dibromide. Third, the dibromide 
was refluxed with 100 ml of 340 mM excess zinc in 1:1 ethanol:acetic acid 
for 3 h. Solvent was removed, and 50 ml of water was added; the suspen-
sion was extracted with three washes of 50 ml of dichloromethane. The or-
ganic layer was dried over sodium sulfate and solvent was removed under 
reduced pressure. The residue was recrystallized from hot acetone to fur-
nish sitosterol as a white solid (mp 137–138°C; literature: 139°C [12]). The 
sitosterol obtained (1.2 g, 29% yield) was determined to be 92% pure based 
upon 1H NMR with impurities of stigmasterol (5%) and stigmastanol (3%).
Each phytosterol ester was generated as follows (illustrated for sitosteryl 
palmitate): 5.4 mmol of palmitoyl chloride were added dropwise to a stirred 
mixture of 3.6 mmol of sitosterol and 0.95 mmol dimethylaminopyridine in 
20 ml of dry pyridine at 50°C. The temperature was then increased to 70°C 
and stirred overnight. The reaction was cooled and diluted with 100 ml of 
water. The resulting suspension was acidified to a pH of 3–4 with 3 M HCl 
and subsequently extracted with three washes of 100 ml of dichloromethane. 
The combined organic layers were dried over sodium sulfate and solvent 
was removed under reduced pressure. The residue was recrystallized from 
hot ethyl acetate to furnish sitosteryl palmitate (2.2 g, 88% yield) as a white 
solid (mp 79–80°C; literature: 85.5°C [12]). Analysis by 1H NMR suggested 
the sitosteryl palmitate was 92% pure and contained approximately 8% of a 
mixture of stigmasteryl and stigmastanyl palmitates.
2.3. PCE activity assay
Lyophilized PCE (100 U) was dissolved in 1 ml of 100 mM potassium 
phosphate buffer at pH 7.0 as recommended by the manufacturer, sepa-
rated into 200 μl aliquots and stored at −80°C until ready to use. Prior to 
use, an aliquot was thawed on ice and diluted to 2 U/ml of the same buf-
fer. The stability of thawed PCE was determined by storing thawed PCE at 
4°C for 0, 5, or 7 days. The hydrolytic activity of the enzyme was tested on 
aliquots of the same solubilized cholesteryl oleate solution and incubated 
as described later, with hydrolysis being measured as the appearance of 
free cholesterol by gas chromathography (GC). No changes in activity were 
seen after 7 days (data not shown); regardless, freshly thawed enzyme was 
used when possible.
A routine enzyme assay was developed and validated to test the sub-
strate specificity of PCE. Sterol esters (8 μmol) were dissolved in chloro-
form and added to 16×100-mm glass, screw-top tubes, and solvent was 
evaporated under N2 at 50°C. Sodium cholate hydrate (100 mg), Tri-
ton X-100 (1 ml) and deionized water (8 ml) were added and tubes were 
capped with PTFE-lined lids. The solution was heated and stirred with a 
stir bar to 100°C until the solution turned white. Solutions were removed 
from heat and slowly cooled to 60°C with stirring, after which 1 ml of a 1 
M, pH 7.0 potassium phosphate buffer was added. The final composition 
of the mixture was 10 ml of 800 μM sterol ester, 1% (w/v) sodium cholate, 
100 mM phosphate buffer and 10% (v/v) Triton X-100. The optimal pH of 
the assay was determined to be 7.0 after testing a pH range of 6.0–8.0 (see 
results). Solutions remained transparent with no sedimentation throughout 
the incubation periods. Using cholesteryl oleate, this mixture was demon-
strated to produce a micelle when separated using high performance gel 
filtration, as previously described by Cohen and Carey [13] and modified 
by Jesch and Carr [14] (data not shown).
The effects of hydrolysis products on the hydrolysis of cholesteryl ole-
ate by PCE under different simulated conditions were determined by add-
ing unesterified stearic, palmitic or oleic acids or cholesterol, sitosterol, 
stigmasterol or stigmastanol to solubilized cholesteryl oleate: 0.8 mM in-
dividual fatty acids were incorporated into the test system to simulate the 
fatty acids present from 100% hydrolysis of test substrates; 16 mM individ-
ual fatty acids were used to test the effects of a larger ratio of free fatty ac-
ids to sterol ester, such as that present in duodenal contents in the fed state; 
2.4 mM free sterol was used to approximate the 3:1 ratio of the Food and 
Drug Administration (FDA)’s recommended daily consumption of phytos-
terols as esters (1.3 g/day phytosterol esters ≈ 2 mmol phytosterols) [15] to 
average cholesterol consumed (257 mg/day ≈ 0.66 mmol cholesterol) [16].
Aliquots of each solubilized sterol ester (0.5 ml) were added to sepa-
rate glass screw top tubes and preheated to 37°C. Dilute PCE (20 μl; 0.04 
U) was added to each tube. Reactions were incubated at 37°C on a rock-
ing platform. Hydrolysis, as measured by the appearance of free sterol or 
stanol by GC, proved to be linear through 16 min of incubation with R2 
> 0.99 for each sterol ester; therefore, subsequent incubation times were 8 
min to ensure sampling from the linear range of the reaction. Hydrolysis 
was stopped and lipids were extracted by Folch lipid extraction [17] by ad-
dition of 2 ml of ice cold 2:1 chloroform:methanol (v/v) containing 50 μM 
5α-cholestane as an internal standard for GC analysis. Stopped reaction 
mixtures were vortexed for 10 s and centrifuged at room temperature at 
1000×g for 10 min; the aqueous supernatant was aspirated and discarded. 
The chloroform in the infranatant was evaporated under nitrogen gas at 
50°C; 1 ml of hexanes was then added to each sample, samples were vor-
texed and the samples were again centrifuged at 1000×g for 10 min. The 
hexanes-soluble supernatant was transferred to a GC vial, while any resid-
ual aqueous layer remained in the infranatant. Hexanes were evaporated 
at 50°C under nitrogen gas; trimethylsyl derivatives were prepared by ad-
dition of 100 μl of Sylon BTZ to each dried sample and subsequently trans-
ferred to a 300 μl GC vial insert. GC vials were capped using PTFE septa, 
and samples were allowed to derivatize for at least 30 min. Samples were 
analyzed by GC using an AT-5 column (Alltech Associates).
2.4. Statistics
Cholesteryl oleate hydrolysis by PCE was used as an external standard 
for each set of reactions. Relative activities were calculated by dividing the 
rate of hydrolysis of individual sterol esters by the within-set hydrolysis 
of cholesteryl oleate. Statistics were computed using the mixed procedure 
of SAS software (version 9.1; SAS Institute, Cary, NC, USA). A two-way 
analysis of variance using sterol and fatty acid moieties as fixed effects was 
computed. Least squares means were calculated, and between-sterol and 
between-fatty acid comparisons were analyzed, as well as individual inter-
action terms of sterol esters, using the “/pdiff” option of “lsmeans.” Bon-
ferroni corrections were made to account for multiple comparisons.
3. Results
3.1. Method validity
Cholesteryl oleate was most effectively hydrolyzed at pH 
7.0, with pH 6.0, 6.5, 7.5 and 8.0 retaining 89%, 80%, 84% and 
72% activity, respectively, relative to pH 7.0. Thus, all sub-
sequent experiments were performed at pH 7.0. In addition, 
no appreciable ester synthesis was observed when PCE was 
added to a solution of cholesterol and oleic acid (data not 
shown). Storage of PCE for up to 7 d at 4°C did not alter its ac-
tivity when measured at 8 and 16 min incubations (data not 
shown). These preliminary experiments ensure that the hydro-
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lytic capabilities of PCE did not change over the course of a set 
of incubations because freshly thawed PCE was used for incu-
bations whenever possible and was never used when stored at 
4°C for more than 2 days.
Optimal incubation times were determined by incubating 
aliquots of a solution of cholesteryl oleate for 0, 0.25, 0.5, 1, 
2, 4, 8, 15, 30 and 60 min (Figure 1). Shorter incubation times, 
specifically at 0.25 and 0.5 min (Figure 1 inset), had higher er-
ror among replicates and did not fit the overall curve well; 
longer incubation times, specifically at 30 and 60 min, were be-
yond the linear region necessary for determining the initial ve-
locity of the reactions. Therefore, subsequent serial reactions 
for each solubilized sterol ester were conducted with incuba-
tion times of 0, 1, 2, 4, 8 and 16 min (Figure 2); hydrolysis was 
linear for each ester through 16 min. To ensure sampling from 
the linear range of the reaction, replicate hydrolysis measure-
ments used only the 8-min time point to determine the initial 
velocity of the reaction.
3.2. Substrate Specificity
The rate of hydrolysis was affected by both the sterol and 
the fatty acid portions of the sterol esters. The average rate of 
hydrolysis of cholesterol esters was significantly greater than 
the average rate of hydrolysis of the esters of the three phytos-
terols (Figure 3; sterol effect: P < .0001). Stigmastanol and si-
tosterol esters were hydrolyzed statistically equally (56.4±1.2% 
and 58.9±1.2%, respectively, normalized to cholesterol esters), 
though more efficiently than stigmasterol esters (29.3±1.3%). 
Additionally, the rate of hydrolysis of sterol esters was signif-
icantly affected by the fatty acid moiety (Figure 3; ester effect: 
P < .0001). Oleate esters, on average, were hydrolyzed most ef-
ficiently, while palmitate and stearate esters were hydrolyzed 
statistically equally (45.8±1.0% and 41.6±1.1%, respectively, 
normalized to oleate esters).
The sterol and ester effects synergistically affected rates of 
hydrolysis when specific sterol esters were considered (Figure 3; 
Figure 1. Confirming kinetic properties of PCE in the experimental as-
say conditions. Cholesteryl oleate was solubilized at a concentration of 
800 μM in a 100 mM, pH 7.0 phosphate buffer containing 1% (w/v) so-
dium-cholate and 10% (v/v) Triton X-100 and hydrolyzed with PCE 
at 37°C for the times indicated on the x-axis. Progression of hydrolysis 
was measured by the appearance of free cholesterol. Data points rep-
resent one replicate, and are fit with a Michaelis–Menten curve. Inset: 
Close-up of incubation times less than 5 min.
Figure 2. Determining the linear region of hydrolysis by PCE in the 
experimental assay conditions. Solubilized sterol esters at a concentra-
tion of 800 μM were hydrolyzed by PCE at 37°C for the times denoted 
on the x-axis. Hydrolysis was measured by the appearance of the re-
spective free sterols. For clarity, only cholesterol esters and the oleate 
esters of the phytosterols are shown, though palmitate and stearate es-
ters of the three phytosterols tested were similarly linear. Data points 
represent the means of two replicates.
Figure 3. Determining relative rates of hydrolysis of 12 sterol esters. 
Solubilized sterol esters at a concentration of 800 μM were incubated 
in the presence of PCE at 37°C for 8 min. Hydrolysis was measured 
by the appearance of the respective free sterols. Cholesteryl oleate was 
used as an external standard for each set of reactions and the average 
hydrolysis of cholesteryl oleate was set to 100% for each set of repli-
cates. Bars represent means ± SEM; n = 4–6 for all esters except choles-
teryl oleate with n = 18. Bars without common letters differ by a Bon-
ferroni adjusted P < .05.
Figure 4. Testing for inhibition of PCE by free sterols. Each sterol was 
added at a concentration of 2.4 mM to an 800 μM solution of choles-
teryl oleate and incubated in the presence of PCE for 8 min at 37°C. 
Hydrolysis of cholesteryl oleate was measured by the appearance of 
free cholesterol. No additional sterol was added to the control, and re-
actions were normalized to the mean of the control within replicates. 
No significant differences were observed among the treatments (P > 
.05). Data points represent single replicates (n = 2); horizontal lines 
represent means.





















interaction effect: P < .0001). In all cases, oleate esters were hy-
drolyzed more efficiently than the palmitate and stearate es-
ters of the same sterol. Further, with the exception of stigmas-
tanyl stearate, hydrolysis of sterol esters was in the order of 
cholesterol > (stigmastanol = sitosterol) > stigmasterol esters 
within a particular acyl group; stigmastanyl stearate was hy-
drolyzed to the same extent as stigmasteryl stearate.
Across all sterol esters tested, cholesteryl oleate was hy-
drolyzed most effectively, while stigmasteryl palmitate and 
stearate were hydrolyzed the least effectively (12.9±1.3% and 
12.6±1.6%, respectively, normalized to cholesteryl oleate). 
Among phytosterol esters, stigmastanyl oleate and sitosteryl 
oleate were statistically equally hydrolyzed at a greater 
rate than the other phytosterol esters tested (64.2±1.3% and 
59.8±1.3%, respectively, normalized to cholesteryl oleate).
In an attempt to determine if the differences in rates of hy-
drolysis were the result of inhibition or activation of PCE by 
hydrolysis products, free sterols or free fatty acids were added 
to a solution of cholesteryl oleate. Creating a three-to-one ra-
tio of free sterols to cholesteryl oleate did not affect hydroly-
sis (Figure 4), nor did the addition of equimolar free fatty acids 
affect hydrolysis (data not shown). However, hydrolysis ap-
peared to be stimulated when a larger ratio of free fatty acids 
to sterol esters was used (Figure 5).
4. Discussion
Disrupting cholesterol micellarization and absorption in the 
intestine have been targets for decreasing cholesterol concentra-
tions in the circulation. Ezetimibe, an inhibitor of NPC1L1 [18], 
and isocoumarin-derived compounds used to inhibit PCE [19] 
are just two examples of pharmaceutical manipulation of cho-
lesterol absorption with the intent of decreasing atheroscle-
rotic risk. At the forefront of nutraceutical therapies, phytos-
terols and their esters have been effective in altering intestinal 
sterol metabolism, though the complete characterization of their 
mechanisms of action has been elusive. In the present study, 
we created an in vitro model to investigate the hydrolysis of se-
lected sterol esters by PCE and determined that PCE is capable 
of hydrolyzing a variety of sterol esters at various rates.
The first consideration in creating our model system was to 
solubilize sterol esters in an aqueous system devoid of other po-
tential substrates for PCE. PCE is a fairly indiscriminant car-
boxyl ester hydrolase, capable of hydrolyzing many of the lip-
ids that are used in typical micelle preparations and that exist in 
micelles in vivo, including phospholipids [7] and acyl glycerols 
[8]. Furthermore, PCE has been reported to catalyze the reverse 
reaction of ester synthesis [20], prompting us to create an aque-
ous model devoid of free fatty acids to avoid encouraging the 
reverse reaction of ester synthesis by altering the equilibrium. 
To avoid using free fatty acids, acyl glycerols or phospholipids 
as amphipathic detergents, we chose to use Triton X-100 [21].
Other considerations for the model system included satis-
fying the bile salt dependency of PCE, and, in particular, the 
preference for a trihydroxy, rather than dihydroxy, bile salt 
[22], which was satisfied by the addition of sodium cholate; the 
potential for pH to affect the hydrolytic capability of PCE [23]; 
the potential for concurrent production and hydrolysis of ste-
rol esters, which may have been prevented by the addition of 
greater than 20mM sodium cholate [24] and the ability to solu-
bilize all esters at equal concentrations. We not only addressed 
these concerns but validated that PCE can perform enzymatic 
hydrolysis in our model system in a reproducible manner.
Once the model hydrolysis system was validated, we dem-
onstrated that PCE, in addition to hydrolyzing various sterol 
esters, exhibited substrate specificity that was affected both by 
the sterol and fatty acid portions of the ester. Saturated esters 
were less well hydrolyzed than the unsaturated ester, with the 
within-sterol palmitate and stearate esters being hydrolyzed 
approximately 40% as well as the oleate ester. A similar dis-
parity was demonstrated with a cholesterol esterase derived 
from rat testis, where cholesteryl stearate was hydrolyzed 
only 25% as well as cholesteryl oleate [25]. Substrate specific-
ity of PCE also appeared to be affected by certain structural 
elements of the individual sterols. The ethyl substitution on 
carbon 24 of the phytosterols is the consistent structural dif-
ference between the phytosterols and cholesterol, and the phy-
tosterol esters were consistently hydrolyzed less efficiently 
than cholesterol esters. The inclusion of the delta 22 double 
bond, which is the only structural difference between sitos-
terol and stigmasterol, coincided with a significant decrease 
in the relative activity of PCE. However, the presence or ab-
sence of the delta five double bond, the only structural differ-
ence between sitosterol and stigmastanol, appeared to have 
little effect on the hydrolytic ability of PCE as evidenced by 
the similar hydrolysis when sitosterol and stigmastanol esters 
are compared. Thus, it could be that small changes to the side 
chain bonded to carbon 17 of these sterols may be more inte-
gral in conferring substrate specificity of PCE than the cyclic 
structure, though this would need to be confirmed by the hy-
drolysis of other sterol esters.
An unexpected result of this study was the increased hy-
drolysis of cholesteryl oleate observed upon addition of larger 
concentrations of free fatty acids. The ratio of free fatty acids 
to sterol ester in these experiments roughly approximated 50% 
hydrolysis of the average consumption of dietary triacylglyc-
erols [16] to the FDA’s recommended intake of phytosterol 
esters [15], thus approximating the initial duodenal contents 
of these components in the fed state. All three fatty acids in-
creased the hydrolysis of cholesteryl oleate as compared with 
the solution initially devoid of fatty acids. Although not dem-
onstrated statistically, it appeared that the more hydrophobic 
fatty acids promoted greater increases in PCE activity. An ex-
planation of the activation of PCE by these fatty acids could be 
the formation of a more native lipid emulsion with which PCE 
could interact, such as that which may exist when free fatty ac-
ids are present in the duodenum in the fed state. This hypoth-
esis is supported by the observations of Nissinen et al. [26] 
that only 40% of plant stanol esters were hydrolyzed in vivo 
on a low fat diet versus 70% on a normal fat diet.
Precedence exists for mammalian systems to distinguish 
between cholesterol and plant sterols, including the higher 
rate of plant sterol efflux via ABCG5/G8 cotransporters [27] 
and the higher rate of esterification of cholesterol as com-
pared with sitosterol in the cytosol of proximal rat intestinal 
cells [28]. Several human studies have also indicated a po-
tential for discrimination among various sterols. In colecto-
mized patients, ingested cholesterol esters were almost com-
pletely hydrolyzed (95%) by the time they reached the feces, 
while 90% of sitosterol esters and only 57% of stigmastanol es-
Figure 5. Testing for modulation of PCE activity by free fatty acids. 
Solubilized cholesteryl oleate at the concentrations denoted on the x-
axis were hydrolyzed in the presence or absence of 16 mM concentra-
tions of each free fatty acid. Data points represent means of and bars 
span two replicates.
740 br o w n, han g, dus s a ul t, & car r i n Jou r na l of nut r i ti o na l Bi o c h em i s t r y  21 (2010) 
ters were hydrolyzed [26]. In another study, the effects of phy-
tosterol esters on proximal digestion and absorption were iso-
lated using duodenal infusion of solubilized sterols and sterol 
esters and measuring the composition in the proximal jeju-
num. The percentage of esterified sitosterol dropped from 64% 
to 27% and esterified stigmastanol from 92% to 39% from infu-
sion to the proximal jejunum [29]. While these studies support 
the present findings, confounding factors such as exposure to 
multiple digestive enzymes, variable emulsion structures and 
diverse concentrations of substrates have made it impossible 
to conclusively determine the hydrolytic activity of PCE alone.
The interaction of phytosterol esters with PCE alone has 
the potential to decrease the hydrolysis of dietary cholesterol 
esters via competitive inhibition and thereby decrease the ab-
sorption of the free cholesterol derived from cholesterol esters. 
However, only a small portion of dietary cholesterol is in the 
esterified form [14]; furthermore, the effects of phytosterol es-
ters are demonstrated whether consumed only once daily or 
multiple times daily [30], which indicates that competition for 
PCE is likely not the only mechanism of action for phytosterols. 
Because the hydrolysis of cholesterol esters would only mini-
mally add to the total cholesterol in the duodenum, competi-
tive inhibition experiments were not conducted in this study.
Here, we have used an in vitro model to demonstrate the 
potential for vastly different efficacies of phytosterol ester sup-
plementation on cholesterol absorption that depends on phy-
tosterol ester structure. However, it is unknown if the in vi-
tro hydrolysis of phytosterol esters reflects hydrolysis in vivo, 
nor is it known by what mechanisms phytosterol ester supple-
mentation most effectively decreases plasma cholesterol. Sev-
eral proposed mechanisms include phytosterols interacting 
with cholesterol transporters, competing with cholesterol for 
micellar solubility, regulating cholesterol-related genes and in-
teracting with digestive enzymes [14]. The evidence support-
ing these mechanisms often has not explored whether phytos-
terol esters or free phytosterols are most effective at inhibiting 
cholesterol absorption. The present study demonstrated that 
phytosterol esters interact with at least one digestive enzyme, 
PCE, while free phytosterols show no effect on cholesterol es-
ter hydrolysis, helping to further understand the mechanisms 
behind the ability of phytosterol and phytosterol ester supple-
mentation to inhibit cholesterol absorption.
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